What is Dunn Meadow?
Dunn Meadow operates at the intersection of healthcare delivery and technological infrastructure, focusing on the modernization of the pharmacy experience. The company addresses systemic inefficiencies in medication access by integrating physical and digital service layers. By prioritizing a concierge approach, Dunn Meadow seeks to solve critical gaps in patient adherence, effectively positioning itself as a high-touch provider in a market increasingly dominated by automated, impersonal pharmacy solutions. Its commitment to a world-class service model is supported by substantial investments in its underlying operational framework.
How much funding has Dunn Meadow raised?
Dunn Meadow has raised a total of $466K across 2 funding rounds:
Debt
$150K
Debt
$316K
Debt (2020): $150K with participation from PPP
Debt (2021): $316K led by PPP
Key Investors in Dunn Meadow
PPP
Public-Private Partnership
What's next for Dunn Meadow?
With the recent influx of capital, Dunn Meadow is poised to scale its infrastructure to meet growing demand for personalized pharmacy services. The strategic focus will likely shift toward expanding its geographic footprint and enhancing its technological stack to further streamline the patient journey. As the company matures, the emphasis will remain on optimizing medication adherence protocols and solidifying its market position as a leader in concierge healthcare. Future growth will depend on the successful integration of these resources to maintain service quality while scaling operations to a broader patient base.
See full Dunn Meadow company page
